Safety and Acceptability of a Vaginal Microbicide

PHASE2CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2007

Conditions

HIV InfectionsHepatitis B, Chronic

Interventions

DRUG

1% tenofovir gel

Trial Locations (3)

NARI Arogya Aadhar Clinic CRS, Pune

Alabama Microbicide CRS, Birmingham

Bronx- Lebanon Hospital Center Clinical Research Site (BLHC CRS), The Bronx

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00111943 - Safety and Acceptability of a Vaginal Microbicide | Biotech Hunter | Biotech Hunter